PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 93 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $359,000 | +2.9% | 139,900 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $349,000 | +20.8% | 139,900 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $289,000 | -33.3% | 139,900 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $433,000 | +36.2% | 139,900 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $318,000 | -37.2% | 139,900 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $506,000 | -29.5% | 139,900 | -33.7% | 0.00% | 0.0% |
Q3 2019 | $718,000 | +35.5% | 211,000 | +86.9% | 0.00% | 0.0% |
Q2 2019 | $530,000 | +51.0% | 112,900 | +7.5% | 0.00% | 0.0% |
Q1 2019 | $351,000 | +25.8% | 105,000 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $279,000 | -52.6% | 105,000 | 0.0% | 0.00% | -66.7% |
Q3 2018 | $588,000 | +10.5% | 105,000 | 0.0% | 0.00% | +50.0% |
Q2 2018 | $532,000 | -16.4% | 105,000 | +12.4% | 0.00% | -33.3% |
Q1 2018 | $636,000 | -25.3% | 93,400 | -17.2% | 0.00% | -25.0% |
Q4 2017 | $851,000 | +1393.0% | 112,800 | +1028.0% | 0.00% | – |
Q3 2017 | $57,000 | +14.0% | 10,000 | 0.0% | 0.00% | – |
Q2 2017 | $50,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
CM Management, LLC | 649,400 | $193,521 | 0.20% |
BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |